Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Stock-based compensation			$ 11,128	$ 8,252
Research and Development Expense
Stock-based compensation	$ 1,337	$ 939	3,842	3,069
Selling, General and Administrative Expenses
Stock-based compensation	$ 2,561	$ 1,709	$ 7,286	$ 5,183